Our study, therefore, attributes a highly tumor-relevant function to Keap1 as it stands to play during the earliest stages of locally growing tumors, during which the cellular burden of mutations is low (Bozic et al., 2010). The gene discussed is KEAP1; the disease is neoplasm.